Luis E. Raez, MD, discusses when minimal residual disease testing can be performed as an option for patients with lung cancer.
Using ctDNA Molecular Residual Disease Testing in Lung Cancer
Luis E. Raez, MD, discusses the current liquid biopsy options for patients with lung cancer through assessing circulating tumor DNA.
Oleg Gligich, MD, discusses utilizing circulating tumor DNA to assess patients with lung cancer.